Skip to content

Clinical trials

Phase 1/2 Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Phase 1/2 Clear all

591 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20015
20028
20034
20046
200514
200614
200718
200817
200917
201014
201119
201222
201311
201419
201521
201634
201743
201825
201933
202025
202131
202237
202346
202429
202531
202629

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed224
Recruiting109
Terminated107
Unknown status53
Active, not recruiting43
Not yet recruiting22
Withdrawn22
Suspended9
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)12
Bristol-Myers Squibb11
Merck Sharp & Dohme LLC7
Cell Genesys6
Eisai Inc.6
GlaxoSmithKline6
Sanofi6
Shenzhen Geno-Immune Medical Institute6
Altor BioScience5
Amgen5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms591
Neoplasm Metastasis75
Carcinoma, Non-Small-Cell Lung66
Melanoma55
Colorectal Neoplasms49
Pancreatic Neoplasms46
Recurrence45
Ovarian Neoplasms42
Breast Neoplasms41
Lung Neoplasms39

Trials

Showing 51 to 75 of 591. Each trial links to its page on Pharma Observatory.

491 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.